DUBLIN (AP) _ Avadel Pharmaceuticals PLC (AVDL) on Wednesday reported third-quarter net income of $21.7 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the Dublin-based company said it had profit of 52 cents.
The specialty pharmaceutical company posted revenue of $39.7 million in the period.
Avadel expects full-year earnings in the range of 25 cents to 35 cents per share, with revenue in the range of $165 million to $175 million.
Avadel shares have declined slightly more than 8 percent since the beginning of the year. The stock has increased slightly more than 1 percent in the last 12 months.